TrialHuman gene therapy2013

Phase I/II trial of adeno-associated virus-mediated alpha-glucosidase gene therapy to the diaphragm for chronic respiratory failure in Pompe disease: initial safety and ventilatory outcomes.

Barbara K Smith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.